- Research note
- Open Access
Parasitic infections in irritable bowel syndrome patients: evidence to propose a possible link, based on a case–control study in the south of Iran
BMC Research Notes volume 13, Article number: 264 (2020)
The current study aimed to evaluate the prevalence of parasitic infections and their possible association with irritable bowel syndrome (IBS), through a case–control study. Stool samples were collected from patients with IBS and healthy subjects and were examined microscopically to detect intestinal parasites.
A total of 200 subjects were enrolled in the study including 100 patients with IBS and 100 healthy controls. The patients were selected based on the Rome III criteria. Of the 100 patients with IBS, 65 (65%) were female and 35 (35%) were male, with a mean age of 42.57 (± 4.07) years. Of these, 30 (30%) were infected with at least one intestinal parasite; the most common ones were Blastocystis hominis and Giardia lamblia. Of the control cases, 64 (64%) were female and 36 (36%) were male, with a mean age of 41.82 (± 11.75) years. Of these, 16 (16%) were infected with at least one intestinal parasite; the most common were B. hominis and Endolimax. There was a significant difference between the rate of parasitic infections between the patients with IBS and the control in particular, B. hominis and G. lamblia. The findings of the study support a possible link between parasitic infections and IBS.
Irritable bowel syndrome (IBS) is a group of diseases of the gastrointestinal tract that is associated with altered bowel movement and abdominal pain, without any known causes . IBS has a profound negative impact on the lives of patients suffering from this syndrome and imposes significant economic and social costs on these patients [2, 3].
The prevalence of IBS is different in various regions of the world, based on the diagnostic criteria. In American and European countries, the prevalence of the disease is reported to be between 9 and 22 percent, respectively . Countries such as India and Thailand [5, 6] have reported a low prevalence of 4.2% and 4.4%, respectively.
In Iran, Mahmoudi et al.  reported an IBS prevalence of 4.2% in a study, based on the Rome I criteria, among Tehran University students while Pourshams et al.  reported the prevalence of this syndrome as 4.7% in a population of students, based on Rome II criteria.
Numerous studies have been conducted to evaluate the association between parasitic, bacterial, and viral infections and IBS. Blastocystis and Dientamoeba fragilis, which are considered to be non-pathogenic parasites, have been linked to the etiology of IBS, in particular, the diarrhea-predominant IBS [9, 10]. While some studies have reported a significant association between the parasitic infections, especially Blastocystis, and IBS [9,10,11], in other studies no link has been found [12,13,14].
In a recent systematic review and meta-analysis focusing on the role of Blastocystis and D. fragilis in IBS, Blastocystis infection, but not D. fragilis infection was found to have a positive association with IBS . Moreover, the meta-analysis reported subtypes 1 and 3 of Blastocystis as potential risk factors for IBS .
Considering the existing discrepancy in the association of parasitic infection and IBS, the current study was conducted to evaluate the prevalence of parasitic infections and their possible association with IBS, through a case–control study in Iran.
The IBS patients were selected from patients referred to internal clinics in university-affiliated hospitals in Shiraz, southern Iran. The inclusion criterion was having IBS, based on Rome III criteria, when examined by two gastroenterologists. The exclusion criteria were having celiac disease, gastrointestinal malignancies, or inflammatory bowel disease. The control subjects were recruited from a healthy population who referred to health centers for a routine check-up without having any complaint of gastrointestinal problems. A predesigned questionnaire was used to obtain sociodemographic, medical history, physical examination, and data related to IBS and parasitic infections. A fresh stool sample was collected from each participant for parasitological evaluation.
Parasitological evaluation of the fecal samples
The physical consistency of fresh fecal samples was classified as being formed or semi-formed. The fecal samples were grossly examined for the presence of blood, mucus, or adult helminthes. The samples were microscopically evaluated for intestinal parasites, using a wet preparation as well as a formalin/ethyl acetate concentration technique .
Statistical analysis of the data was performed, using SPSS (version 18; SPSS Inc., Chicago, IL, USA). The independent sample t-test was used to compare the means of different variables in two studied groups. Chi square, as well as Fisher’s exact tests, was used for comparing the discontinuous or categorical variables. P-value < 0.05 was considered statistically significant.
Features of IBS patients and their parasitic infection
A total of 200 subjects were enrolled in the study including 100 IBS patients and 100 healthy controls. Of the 100 patients with IBS, 65 (65%) were female and 35 (35%) were male, with a mean age of 42.57 ± 14.07 years (range 14-80 years). The mean duration of disease in the patient group was 4.33 (± 4.68) years with the lowest duration being 3 months and the longest 25 years.
Out of the 100 patients, 37 (37%) had an underlying disease, the most common of which were hypothyroidism (5%), hyperlipidemia (5%), coronary artery diseases (5%), and psychiatric disorders (4%).
Of the patients with IBS, 30 (30%) were infected with at least one intestinal parasite. The most common parasitic infections were B. hominis (15%) and G. lamblia (8%). Polyparasitism was found in 5 cases, including one (1%) with G. lamblia and B. hominis, two (2%) with B. hominis and E. nana, and 2 (2%) with B. hominis and Entamoeba coli.
With respect to daily stress and anxiety, 72 (72%) of the patients reported high levels of stress and anxiety. It should be noted that none of the patients with IBS had celiac disease, gastrointestinal malignancies, or inflammatory bowel disease, based on ultrasound, colonoscopy, and endoscopic examinations.
Features of control subjects and their parasitic infection
In the control group, 64 (64%) were female and 36 (36%) were male. The mean age of the control group was 41.82 (± 11.75) years, ranging from 17 to 75 years. The differences between the age and sex of the patients and controls were not significant when statistically analyzed.
In the control group, 16 (16%) cases were infected with at least one intestinal parasite; the most common were B. hominis and E. nana. In the control group in 86 (86%) cases, stool consistency was formed and in 14 cases (14%) it was semi-formed.
Comparison of the rate and diversity of parasitic infection in patients with IBS and controls
Analysis of data by independent sample t-test revealed a significant difference between the rate of parasitic infections in the patients with IBS and the control group (p = 0.019, df = 198, F = 23.64). There was also a statistically significant difference between patients with IBS and the control group regarding underlying diseases where the rate of these diseases was higher in patients with IBS. Furthermore, there was a statistically significant difference between the patients and the control group regarding the level of daily stress and anxiety, as well as the level of psychiatric disorders (p < 0.05). There was no statistically significant difference in the fecal specimen consistency between the patients and the control group.
With regard to the type of parasitic infection, there was a significant difference between the two groups concerning G. lamblia and B. hominis infections. In terms of polyparasitism, there was a significant statistical difference between the patients with IBS and the control group. Table 1 shows the demographic characteristics and differences between the control and Patients with IBS in the current study.
The present study investigated the prevalence of intestinal parasites in patients with IBS and healthy controls. Of the 100 patients studied, 30 (30%) were infected with at least one intestinal parasite and G. lamblia and Blastocystis spp. were the most common. Differences in the rate of parasitic infection, in particular B. hominis and G. lamblia, between the patients with IBS and controls were statistically significant.
Blastocystis spp. is a common intestinal protozoan and its role as a parasitic pathogen is still controversial. The contribution of Blastocystis to IBS has been proposed in several studies [9,10,11]. The findings of the current study are consistent with previous studies, in that a higher rate of parasitic infection in patients with IBS was presented, in comparison with the healthy controls [9,10,11]. In Jimenez-Gonzalez et al. study , a significant association between Blastocystis infection and IBS was reported in the Mexican patient population, where the rate of infection with this parasite was higher in patients with IBS than in the control group.
In concordance with our findings, other reports from Europe, Mexico, India, the Middle East, and Pakistan, proposed for the role of Blastocystis in the pathogenicity of IBS [11, 16, 17]. Moreover, a systematic review and meta-analysis in Iran supported the existence of a positive association between Blastocystis infection and IBS . The yield of infection in patients with IBS has been reported to be higher than that of healthy counterparts, where patients with IBS had significantly more B. hominis per microscopic field .
On the other hand, several studies have not found a positive association between Blastocystis infection and IBS [12,13,14, 19]. Krogsgaard et al.  showed that both D. fragilis and Blastocystis spp. parasites are more prevalent in healthy subjects than in patients with IBS. Yakoob et al.  evaluated the rate of B. hominis and D. fragilis infections in IBS-diarrhea patients and controls. Although the rate of both infections was higher in patients with IBS, the author concluded that a prospective study with a larger population was needed to support any association between IBS and these parasitic infections. In another study by Khademvatan et al.  in Khuzestan, south of Iran, 122 patients with IBS and 122 healthy individuals were evaluated for Blastocystis infection where no statistically significant difference was found between the two groups. In another study in Iran, Beiromvand et al.  demonstrated that Blastocystis spp. was more prevalent in the control group in comparison with the patients with IBS. In a study in Thailand,  no significant difference was found in the incidence of Blastocystis in patients with IBS and healthy controls. In Morgan et al.  study no association was found between IBS and parasitic infections in a developing nation environment, Leon Municipality, where the rate of parasitic infection is substantial.
In the current study, G. lamblia was more prevalent in stool samples of patients with IBS than in the controls. This is in agreement with previous studies that reported a higher rate of G. lamblia in patients with IBS [16, 23].
The association between the genotypes of B. hominis with IBS is controversial. In a study by Yakoob et al.  in Karachi, Pakistan, type 1 of Blastocystis was predominant in the patients with IBS whereas type 3 was more common in the control group. Also researchers from Egypt reported genotype I as the dominant genotype of B. hominis in patients with IBS . Such association was not found in the study of Khademvatan et al.,  in Iran. In our study, the genotypes of B. hominis were not determined.
In this case–control study, concerning the potential role of parasitic infection in IBS status, a significant difference in the prevalence of Blastosystis spp and G. lamblia was seen in patients with IBS in comparison with the control group. The findings are in line with those researchers who reported a link between parasitic infections and IBS. Whether this is a causative, risk factor or an association between parasitic infection and IBS deserve further studies. Results of the present study also support an association between psychiatric disorders and IBS. Further studies with a larger sample size are needed to clarify the role of parasitic infections in the pathogenesis of IBS.
There are several limitations to this study. First, the sample size of the study is relatively small. Second, the genotypes of Blastocystis have not been assessed to investigate the possible association of the Blastocystis subtypes and IBS. Also, the literacy levels of the two groups were somewhat different, which may, to some extent, have affected the rate of parasite infection in the two studied groups.
Availability of data and materials
Any further requested information regarding the experimental and data analysis during the current study is available from the corresponding author on request.
Irritable bowel syndrome
Locke GR, Olden K, Peterson W, Quigley E, Schoenfeld P, Schuster M, Talley N. Systematic review on the management of irritable bowel syndrome in North America. Am J Gastroenterol. 2002;97:S7–26.
Chang L. Review article: epidemiology and quality of life in functional gastrointestinal disorders. Aliment Pharmacol Ther. 2004;20(Suppl 7):31–9.
Hulisz D. The burden of illness of irritable bowel syndrome: current challenges and hope for the future. J Manag Care Pharm. 2004;10(4):299–309.
Cremonini F, Talley NJ. Irritable bowel syndrome: epidemiology, natural history, health care seeking and emerging risk factors. Gastroenterol Clin North Am. 2005;34(2):189–204.
Danivat D, Tankeyoon M, Sriratanaban A. Prevalence of irritable bowel syndrome in a non-Western population. Br Med J. 1988;296(6638):1710.
Ghoshal UC, Abraham P, Bhatt C, Choudhuri G, Bhatia SJ, Shenoy KT, Banka NH, Bose K, Bohidar NP, Chakravartty K, et al. Epidemiological and clinical profile of irritable bowel syndrome in India: report of the Indian Society of Gastroenterology Task Force. Indian J Gastroenterol. 2008;27(1):22–8.
Mahmudi S, Pourshams A, Akbari M, Malekzadeh R. The prevalence of irritable bowel syndrome and gastroesophageal reflux disease among Tehran University students. Govaresh. 2012;8(4):159–62.
Pourshams A, Zendehdel N, Semnani M, Semnani U. Irritable bowel syndrome and psychiatric disorders Amang University Freshmen. Govaresh. 2012;11(1):22–6.
Jimenez-Gonzalez DE, Martinez-Flores WA, Reyes-Gordillo J, Ramirez-Miranda ME, Arroyo-Escalante S, Romero-Valdovinos M, Stark D, Souza-Saldivar V, Martinez-Hernandez F, Flisser A, et al. Blastocystis infection is associated with irritable bowel syndrome in a Mexican patient population. Parasitol Res. 2012;110(3):1269–75.
Yakoob J, Jafri W, Beg MA, Abbas Z, Naz S, Islam M, Khan R. Blastocystis hominis and Dientamoeba fragilis in patients fulfilling irritable bowel syndrome criteria. Parasitol Res. 2010;107(3):679–84.
Rostami A, Riahi SM, Haghighi A, Saber V, Armon B, Seyyedtabaei SJ. The role of Blastocystis sp. and Dientamoeba fragilis in irritable bowel syndrome: a systematic review and meta-analysis. Parasitol Res. 2017;116(9):2361–71.
Khademvatan S, Masjedizadeh R, Rahim F, Mahbodfar H, Salehi R, Yousefi-Razin E, Foroutan M. Blastocystis and irritable bowel syndrome: frequency and subtypes from Iranian patients. Parasitol Int. 2017;66(2):142–5.
Surangsrirat S, Thamrongwittawatpong L, Piyaniran W, Naaglor T, Khoprasert C, Taamasri P, Mungthin M, Leelayoova S. Assessment of the association between Blastocystis infection and irritable bowel syndrome. J Med Assoc Thai. 2010;93(Suppl 6):S119–24.
Tungtrongchitr A, Manatsathit S, Kositchaiwat C, Ongrotchanakun J, Munkong N, Chinabutr P, Leelakusolvong S, Chaicumpa W. Blastocystis hominis infection in irritable bowel syndrome patients. Southeast Asian J Trop Med Public Health. 2004;35(3):705–10.
Sarkari B, Hosseini G, Motazedian MH, Fararouei M, Moshfe A. Prevalence and risk factors of intestinal protozoan infections: a population-based study in rural areas of Boyer-Ahmad district, Southwestern Iran. BMC Infect Dis. 2016;16(1):703.
Jadallah KA, Nimri LF, Ghanem RA. Protozoan parasites in irritable bowel syndrome: a case-control study. World J Gastrointest Pharmacol Ther. 2017;8(4):201.
Yakoob J, Jafri W, Beg MA, Abbas Z, Naz S, Islam M, Khan R. Irritable bowel syndrome: is it associated with genotypes of Blastocystis hominis. Parasitol Res. 2010;106(5):1033–8.
Giacometti A, Cirioni O, Fiorentini A, Fortuna M, Scalise G. Irritable bowel syndrome in patients with Blastocystis hominis infection. Eur J Clin Microbiol Infect Dis. 1999;18(6):436–9.
Krogsgaard LR, Andersen LO, Johannesen TB, Engsbro AL, Stensvold CR, Nielsen HV, Bytzer P. Characteristics of the bacterial microbiome in association with common intestinal parasites in irritable bowel syndrome. Clin Transl Gastroenterol. 2018;9(6):161.
Krogsgaard LR, Engsbro AL, Stensvold CR, Nielsen HV, Bytzer P. The prevalence of intestinal parasites is not greater among individuals with irritable bowel syndrome: a population-based case-control study. Clin Gastroenterol Hepatol. 2015;13(3):507–13.
Beiromvand M, Hashemi SJ, Arjmand R, Sadjadei N, Hardanipasand L. Comparative prevalence of blastocystis in patients with the irritable bowel syndrome and healthy individuals: a case control study. Jundishapur J Microbiol. 2017;10:6.
Morgan DR, Benshoff M, Caceres M, Becker-Dreps S, Cortes L, Martin CF, Schmulson M, Pena R. Irritable bowel syndrome and gastrointestinal parasite infection in a developing nation environment. Gastroenterol Res Pract. 2012;2012:343812.
Hanevik K, Dizdar V, Langeland N, Hausken T. Development of functional gastrointestinal disorders after Giardia lambliainfection. BMC Gastroenterol. 2009;1:27.
Fouad SA, Basyoni MM, Fahmy RA, Kobaisi MH. The pathogenic role of different Blastocystis hominis genotypes isolated from patients with irritable bowel syndrome. Arab J Gastroenterol. 2011;12(4):194–200.
The technical assistance of Dr. N. Arefkhah and Mrs. Fariba Ghorbani is acknowledged.
The study was financially supported by the office of vice-chancellor for research of Shiraz University of Medical Sciences (Grant No. 93-01-01-8586). The study was the subject of Dr. Z. Shafiei MD dissertation.
Ethics approval and consent to participate
The protocol of this study was approved by the Ethical Committee of Shiraz University of Medical Sciences (Sums). Written informed consent was provided by all participants.
Consent for publication
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Shafiei, Z., Esfandiari, F., Sarkari, B. et al. Parasitic infections in irritable bowel syndrome patients: evidence to propose a possible link, based on a case–control study in the south of Iran. BMC Res Notes 13, 264 (2020). https://doi.org/10.1186/s13104-020-05118-x
- Parasitic infection
- Blastocystis spp.
- Giardia lamblia